Maharashtra FDA Chief Promises Action on Corruption Allegations

FDA Commissioner Tukaram Mundhe vows to investigate claims of officials soliciting bribes from food businesses.

A
Apla Nagpur Desk
29 Sept 2026, 8:18 AM IST · 2 min read
Source: Mid-day
Maharashtra FDA Chief Promises Action on Corruption Allegations
KEY TAKEAWAYS
1

Sanjay Raut alleges FDA officials demanded money from food businesses.

2

Tukaram Mundhe will take action if allegations are substantiated.

3

The investigation follows a letter detailing misconduct by FDA personnel.

Tukaram Mundhe, the Commissioner of the Maharashtra Food and Drug Administration (FDA), has stated that he will take appropriate measures if allegations of corruption against FDA officials are confirmed. This announcement comes in response to claims made by Sanjay Raut, a Rajya Sabha MP from the Shiv Sena (UBT), who accused certain officials of soliciting bribes from food establishments, including hotels and quick-commerce firms.

The allegations surfaced in a letter sent by Raut to Mundhe on September 26, wherein he detailed instances of FDA officials allegedly misusing their authority. According to Raut, these officials threatened businesses with the suspension of their licenses unless they paid money for reinstatement. The letter, however, did not provide specific evidence to support these claims, prompting Mundhe to emphasize the need for a thorough investigation.

Mundhe, while addressing the media, acknowledged the seriousness of the allegations and assured that the matter would be scrutinized. He stated, "The letter sent by Sanjay Raut does not carry any specific details. I will look into the matter, and if I find the allegations to be true, action will be initiated against those responsible."

The implications of these allegations are significant for the food industry in Maharashtra, as they could undermine public trust in regulatory bodies. If proven true, the actions of the implicated FDA officials could lead to a broader investigation into corruption within the agency, potentially affecting its operations and credibility.

Looking ahead, the FDA is expected to conduct a detailed inquiry into the allegations. The outcome of this investigation could result in disciplinary actions against those found guilty of misconduct, as well as reforms aimed at preventing such issues in the future. Stakeholders in the food industry are closely monitoring the situation, hoping for a resolution that restores integrity to the regulatory process.

💬What did you think of this story?What did you think?

Read Next